Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Heron Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 190
- +30 vs. Q1 2024
- Shares held
- 129.6M
- +10.3M (+8.6%) vs. Q1 2024
- Total value
- $453.7M
- +$123.2M (+37.3%) vs. Q1 2024
- New holders
- 45
- 67 more added
- Sold out
- 15
- 39 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 163 | $57.1M |
| Q1 2026 | 167 | $125.6M |
| Q4 2025 | 170 | $203.2M |
| Q3 2025 | 172 | $192.4M |
| Q2 2025 | 171 | $272.1M |
| Q1 2025 | 165 | $274.5M |
| Q4 2024 | 161 | $175.8M |
| Q3 2024 | 173 | $242.4M |
| Q2 2024 | 190 | $453.7M |
| Q1 2024 | 161 | $330.5M |
| Q4 2023 | 151 | $191.2M |
| Q3 2023 | 141 | $121.9M |
| Q2 2023 | 149 | $114.7M |
| Q1 2023 | 162 | $163.1M |
| Q4 2022 | 176 | $289.5M |
| Q3 2022 | 186 | $514.2M |
| Q2 2022 | 174 | $321.6M |
| Q1 2022 | 186 | $620.5M |
| Q4 2021 | 200 | $1.07B |
| Q3 2021 | 197 | $1.16B |
| Q2 2021 | 189 | $1.61B |
| Q1 2021 | 193 | $1.48B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Heron Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,964−100.0% | Sold out |
| Future Financial Wealth Managment LLC | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Game Plan Financial Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −72−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |